ag 127 and Leukemia, Pre-B-Cell

ag 127 has been researched along with Leukemia, Pre-B-Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goi, K; Inukai, T; Kagami, K; Kojika, S; Lijima, K; Miyamoto, N; Nakamura, M; Nakazawa, S; Sugita, K; Tezuka, T1

Other Studies

1 other study(ies) available for ag 127 and Leukemia, Pre-B-Cell

ArticleYear
The JAK2 inhibitor AG490 predominantly abrogates the growth of human B-precursor leukemic cells with 11q23 translocation or Philadelphia chromosome.
    Leukemia, 2001, Volume: 15, Issue:11

    Topics: Antineoplastic Agents; Cell Division; Chromosomes, Human, Pair 11; DNA, Neoplasm; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Humans; Janus Kinase 2; Leukemia, Lymphoid; Philadelphia Chromosome; Phosphorylation; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Translocation, Genetic; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tyrphostins

2001